A Closer Look at Evolving Treatment Strategies for Rheumatoid Arthritis

Download slides from a live presentation of the latest RA treatment trends.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: November 6, 2020

Download slides from a live presentation with expert insights on pivotal trials and the newest data on JAK inhibitors.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 4, 2020

Download slides from a live presentation of tips for patient-centered care in RA.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 4, 2020

Download this short summary of JAK inhibitors in bDMARD-IR, MTX-IR, and MTX-naive RA, plus critical insights on shared decision-making.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: November 13, 2020

Hear a lively discussion of the latest RA treatment trends, tips for patient-centered care, and expert insights on the newest data.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses: 1.5 Nursing contact hours Released: December 7, 2020 Expired: December 6, 2021

Targeted DMARDs: An Evolving Landscape

Efficacy of Newer Strategies

JAK Inhibitor Safety Data

JAK Inhibitor Use in the Clinic: What Do We Know?

Treat-to-Target in RA: Using a Shared Decision-Making Approach

Questions and Answers

Hear a lively discussion of the latest rheumatoid arthritis treatment trends from expert faculty Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 11, 2020

Expert faculty Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the latest data on JAK inhibitors in bDMARD-IR, MTX-IR, and MTX naïve patients with RA.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 11, 2020

Expert faculty Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss tips for patient-centered care in RA.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 11, 2020

What is the place of JAK inhibitors in the treatment of RA? Read expert answers to audience questions from a CCO Webinar on current best practices and emerging options for patients with RA.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 10, 2020

What is the safety of JAK inhibitors in the treatment of RA? Read expert answers to audience questions from a CCO Webinar on current best practices and emerging options for patients with RA.

Stanley B. Cohen, MD Sheetal Desai, MD, MSEd Eric M. Ruderman, MD Released: December 18, 2020

The new guidelines may level the playing field between TNF inhibitors and JAK inhibitors.

Stanley B. Cohen, MD Released: December 23, 2020